Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-13Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
-
CLINICAL_TRIALS study record update · 2026-03-12Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase I/II Study of Nula-cel in Autologous CD34+ Hematopoietic Stem Cells to Convert HbS to HbA for Treating Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-10Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-10Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-09High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-09Double-blind, Randomized, Placebo Controlled Study to Evaluate Optimal Timing of Ketamine Initiation
-
CLINICAL_TRIALS study record update · 2026-03-09Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults: A Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2026-03-09A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-05Pilot Study to Evaluate the Safety and Feasibility of Induction of Mixed Chimerism in Sickle Cell Disease Patients With COH-MC-17: a Non-Myeloablative, Conditioning Regimen and CD4+ T-cell-depleted Haploidentical Hematopoietic Transplant
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene (GLOBE1 βAS3 Modified Autologous CD34+ Cells) in Patients With Sickle Cell Disease (SCD)
-
CLINICAL_TRIALS study record update · 2026-03-05Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II: A Multicenter, Open-label, Single-arm Type I Hybrid Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-05A Comparative Observational Study to Evaluate the Safety and Effectiveness of Xromi (Hydroxycarbamide Oral Solution 100mg/ml) for the Prevention of Vaso-occlusive Complications of Sickle Cell Disease in Children Under 2 Years of Age.
-
CLINICAL_TRIALS study record update · 2026-03-04Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
-
CLINICAL_TRIALS study record update · 2026-03-04A Phase 1/2 Open Label Cohort Study Evaluating the Efficacy and Safety of Gene Therapy of the Sickle Cell Disease (SCD) by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains Autologous CD34+ Cells Transduced ex Vivo by the Bifunctional βAS3m/miR7m Lentiviral Vector Expressing the Therapeutical Beta-globin βAS3m and a Micro-RNA (miRNA) Targeting Specifically the Endogenous βS-globin mRNA.
-
CLINICAL_TRIALS study record update · 2026-03-03Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
-
CLINICAL_TRIALS study record update · 2026-03-02The SickleFit Exercise and Nutrition Randomized Control Trial for Older Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-02-27RCT of Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-02-27Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-02-27The Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) Intervention: A Randomized Controlled Trial for Adolescents With Sickle Cell Disease to Prepare for Transition of Care
-
CLINICAL_TRIALS study record update · 2026-02-24Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
-
CLINICAL_TRIALS study record update · 2026-02-23Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-02-20Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-02-18A Compassionate Release Protocol: Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts
-
CLINICAL_TRIALS study record update · 2026-02-18Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease